Bull/Bear Index 47.2/100
→
IBK Investment & Securities lowers GC Pharma's target price to 190,000 won... expects recovery in the second half of 2026
Key takeaway
"IBK Investment & Securities lowers GC Pharma's target price to 190,000 won... expects recovery in the second half of 2026" — BullBear's AI rates this story as a bearish (negative) signal for markets, with a market-impact score of 50 out of 100. Reported by TokenPost on July 22, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Catch the next bear flag
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 40.0%.
Join Telegram channel
or scan with phone →
